Health Condition 1: D649- Anemia, unspecified
Conditions
Interventions
None listed
Sponsors
Ram Swaroop Pharmacy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of either sex, aged 18 to 65 years. 2.Patients diagnosed with anaemia and haemoglobin levels lessthan 12 g per dL for women and lessthan 13g perdL for men. 3. Willingness to provide informed consent and comply with all study procedures. 4. Ability to attend study visits and follow the treatment plan. 5. General Health: Patients in generally stable health, with anaemia as their primary condition Mainly severe anemia cases.
Exclusion criteria
Exclusion criteria: 1. Pregnancy and Lactation Pregnant or lactating women are excluded due to safety concerns. 2. Severe Anaemia Patients with a history of chronic or congenital anaemia. 3. Recent Transfusions Patients who have undergone blood transfusions within the past three months. 4. Systemic Diseases Patients with systemic diseases like uncontrolled hypertension, uncontrolled diabetes, or tuberculosis. 5. Allergies Known allergies or hypersensitivity to any of the ingredients in HB Vista. 6. Concomitant Diseases Patients with other severe medical conditions that could interfere with the study outcomes or pose a risk to patient safety
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in haemoglobin concentration is in g per dL from baseline to the end of the study period. The main outcome measure will be the increase in haemoglobin levels in patients from the start to the completion of treatment.Timepoint: Day0, Day1,Day20, Day40, Day60 | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in Quality of Life is Measured using a validated QoL scale to be defined, capturing patient-reported outcomes related to well-being, energy levels, and ability to perform daily tasks.Timepoint: Day0, Day1,Day20, Day40, Day60 | — |
Countries
India
Contacts
Public ContactMs Arpita Malgi
SAMAHITHA RESEARCH SOLUTIONS
Outcome results
None listed